Adma Biologics Inc Earnings

Adma Biologics Inc’s revenue jumped 18.39% since last year same period to $139.16Mn in the Q4 2025. On a quarterly growth basis, Adma Biologics Inc has generated 3.68% jump in its revenue since last 3-months.

Adma Biologics Inc’s net profit fell -55.87% since last year same period to $49.38Mn in the Q4 2025. On a quarterly growth basis, Adma Biologics Inc has generated 35.55% jump in its net profits since last 3-months.

Adma Biologics Inc’s net profit margin fell -62.72% since last year same period to 35.48% in the Q4 2025. On a quarterly growth basis, Adma Biologics Inc has generated 30.74% jump in its net profit margins since last 3-months.

Adma Biologics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.19 - a 24.47% jump from last quarter’s estimates.

Adma Biologics Inc’s earning per share (EPS) estimates for the current year stand at 0.19.

Adma Biologics Inc’s earning per share (EPS) jumped 58.6% since last year same period to 0.22 in the Q4 2025. This indicates that the Adma Biologics Inc has generated 58.6% annual rate of jump in its earning per share (EPS) in the last 4 quarters.